SCHEMBL6225809

SCHEMBL6225809

O=C(CCCCl)Cc1cccc(I)c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.43
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
THPO P40225 1/20 0.39
RAB9A P51151 1/20 0.39
HIF1A Q16665 1/20 0.39
IDO1 P14902 2/20 0.39
SIGMAR1 Q99720 4/20 0.38
LMNA P02545 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FOLH1 Q04609 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29237352 0.83 MAPK8 (0.43) MAPK8CYP1A2CYP2D6CYP2C19THPO
SCHEMBL3832809 0.81 GLS (0.46) MAPK8SIGMAR1
SCHEMBL6223832 0.81 VNN1 (0.50) MAPK8SIGMAR1
SCHEMBL6223798 0.80 TDP1 (0.38) SIGMAR1TDP1L3MBTL1
SCHEMBL3893395 0.79 L3MBTL1 (0.51) SMN1; SMN2TDP1L3MBTL1
SCHEMBL20346346 0.77 YWHAG (0.40) MAPK8CYP1A2CYP2D6CYP2C19THPO
SCHEMBL6226325 0.77 MEN1 (0.51) MAPK8CYP1A2CYP2D6CYP2C19SIGMAR1
SCHEMBL27383376 0.76 MAPK8 (0.43) MAPK8CYP1A2CYP2D6CYP2C19THPO
SCHEMBL10386674 0.75 CYP1A2 (0.46) MAPK8CYP1A2CYP2D6CYP2C19THPO
SCHEMBL6594686 0.74 L3MBTL1 (0.50) SMN1; SMN2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed